Lv5
880 积分 2022-11-25 加入
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial
13小时前
待确认
Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial)
1个月前
已完结
LBA75 Neoadjuvant chemoradiotherapy followed by surgery versus active surveillance for oesophageal cancer (SANO-trial): A phase-III stepped-wedge cluster randomised trial
4个月前
已完结
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study
4个月前
已完结
Optimizing Organ-Preservation Strategies Through Chemotherapy-Based Selection in Esophageal Squamous Cell Carcinoma: Results From the CROC Multi-Institutional Phase 2 Clinical Trial
4个月前
已完结
Parallel-Group Controlled Trial of Surgery Versus Chemoradiotherapy in Patients With Stage I Esophageal Squamous Cell Carcinoma
4个月前
已完结
Definitive chemoradiotherapy has comparable survival outcomes to esophagectomy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: real-world data
4个月前
已完结
NPM1 inhibits tumoral antigen presentation to promote immune evasion and tumor progression
5个月前
已完结
NLRC5 senses NAD+ depletion, forming a PANoptosome and driving PANoptosis and inflammation
6个月前
已完结
Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5
6个月前
已完结
皖公网安备34019202002308
